945. Treating multidrug-resistant S. aureus
Session: Symposium: How to Treat Resistant Gram-Positive Infections
Friday, October 5, 2018: 10:30 AM
Room: N 24
Thomas L. Holland, MD, Duke University Medical Center, Durham, NC

Thomas Holland, M.D. is an infectious diseases specialist at Duke University. He also holds a faculty appointment at the Duke Clinical Research Institute. His research has focused on clinical trials in staphylococcal infections, particularly bacteremia and endocarditis, as well as skin and soft tissue infections and hospital-acquired and ventilator-associated pneumonia. He has developed multiple trial protocols related to Gram-positive infections through his work with the Antibacterial Resistance Leadership Group and the Clinical Trials Transformation Initiative.


Disclosures:

T. L. Holland, Basilea: Consultant , Consulting fee . Motif Bio: Consultant and Scientific Advisor , Consulting fee . Theravance: Consultant , Speaker honorarium . Genentech: Consultant , Consulting fee .

Previous Presentation | Next Presentation >>

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.